Don’t invest unless prepared to lose all the money you invest. This is a high-risk investment, you shouldn’t expect to be protected if something goes wrong. GlaxoSmithKline (GSK)—a global ...

North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global healthcare company has made a huge difference in the biotech scene here, ...

This is how Giulia Manfrini, a 36-year-old influencer from Venaria Reale (Turin), died, a victim of a swordfish attack yesterday morning in the Mentawai Islands, Indonesia.

Giulia Manfrini, born in Venaria Reale in 1988, was a versatile athlete and passionate about sports since she was a child. She started with skiing and then moved to snowboarding, where she ...

If the market demands a combustion-powered Giulia, Alfa Romeo could provide it. The next-generation model will be underpinned by the Stellantis STLA Large architecture. A successor to the range ...

Dezeen Showroom: workplace furniture brand Narbutas worked with Italian design studio Baldanzi & Novelli on a range of seating that sets out to enhance the wellbeing of people working in office ...

The market for four-door performance sedans is becoming increasingly thin in 2024, as greater focus is placed on making high-riding SUVs go really fast. Of course, the segment stalwarts remain.

“In 2021, G21 CEO Giulia Baggio identified some historic financial irregularities during an internal audit of the payment systems,” Ms Stephens said. “At the conclusion of the ...

Featured here, the Income Statement (earnings report) for Glaxo Smith Kline, showing the company's financial performance from operating and non operating activities such as revenue, expenses and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna A spokesperson for Massachusetts-based Moderna said the company was aware of the ...

(Reuters) -British drugmaker GlaxoSmithKline (NYSE:GSK) sued Moderna (NASDAQ:MRNA) in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA ...